Listed by the USPTO as PAK, MICHAEL D
Tech Center 1600 • Art Units: 1644 1646 1654 1674 1682 1699
This examiner grants 59% of resolved cases
Michael D. Pak works in Tech Center 1600 and art unit 1644. His record includes 711 resolved cases, a 58.6% allowance rate, and a median of 1365 days to allowance. The figures indicate a substantial prosecution history with a timeline that may require applicants to maintain strategy over an extended period.
The interview lift is 29.9%, showing a meaningful recorded association between interviews and allowance outcomes. The leading companies are Morphosys GmbH, Regeneron Pharmaceuticals Inc., and Carnegie Mellon University. The leading firms are Baker, Donelson, Bearman, Caldwell & Berkowitz, PC, BROWN RUDNICK LLP, and Conley Rose, P.C. Counsel may use interviews alongside careful written prosecution to manage complex or persistent examination issues.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 15034531 | COMPOSITIONS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS AND METHODS OF USING SAME | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 18006997 | NITRO COMPOUND DETECTION ELEMENT | Non-Final OA | SUMITOMO CHEMICAL COMPANY, LIMITED |
| 18683790 | TREATMENT OF CLUSTER HEADACHE USING ANTI-CGRP ANTIBODIES | Non-Final OA | H. Lundbeck A/S |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy58.6% of resolved applications examined by Michael D Pak were allowed (711 resolved cases), compared with 35.9% across Art Unit 1644 over the last five years.
This examiner's interview lift is +29.9 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Michael D Pak took 1,365 days on average from filing to allowance.
Michael D Pak examines applications in Art Unit 1644 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
